Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M707Revenue $M320Net Margin (%)-3.3Altman Z-Score2.2
Enterprise Value $M866EPS $-0.3Operating Margin %0.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.2Pre-tax Margin (%)-3.1Higher ROA y-yN
Price/Book2.710-y EBITDA Growth Rate %--Quick Ratio2.4Cash flow > EarningsY
Price/Sales2.05-y EBITDA Growth Rate %--Current Ratio3.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-41.6ROA % (ttm)-1.9Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-4.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M35.5ROIC % (ttm)56.3Gross Margin Increase y-yN

Gurus Latest Trades with AMRI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AMRIJoel Greenblatt 2014-09-30 Sold Out -0.03%$18.7 - $22.89
($20.45)
$ 19.93-3%Sold Out0
AMRIJoel Greenblatt 2014-06-30 Reduce-0.03%$14.63 - $19.89
($16.89)
$ 19.9318%Reduce 47.95%102,934
AMRIGeorge Soros 2014-06-30 Sold Out -0.01%$14.63 - $19.89
($16.89)
$ 19.9318%Sold Out0
AMRIGeorge Soros 2014-03-31 Buy 0.01%$10.08 - $19.91
($13.57)
$ 19.9347%New holding48,700
AMRIJoel Greenblatt 2013-09-30 Buy 0.1%$10.81 - $13.72
($12.29)
$ 19.9362%New holding228,216
AMRIJohn Rogers 2013-03-31 Sold Out -0.04%$5.28 - $10.84
($7.56)
$ 19.93164%Sold Out0
AMRIJohn Rogers 2012-12-31 Reduce-0.01%$3.45 - $5.5
($4.25)
$ 19.93369%Reduce 27.34%372,844
AMRIJohn Rogers 2012-06-30 Buy 0.03%$2.32 - $3.22
($2.81)
$ 19.93609%New holding473,769
AMRIFirst Eagle Investment 2010-12-31 Sold Out $5.05 - $6.93
($5.92)
$ 19.93237%Sold Out0
AMRIFirst Eagle Investment 2010-06-30 Buy $5.1 - $8.86
($7.07)
$ 19.93182%New holding10,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AMRI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


AMRI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-08-17Sell1,000$20.45-2.54 view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-08-07Sell5,000$21.06-5.37 view
D AMBRA THOMAS E PHDDirector 2015-06-10Sell20,000$19.770.81 view
D AMBRA CONSTANCE M10% Owner 2015-06-10Sell20,000$19.770.81 view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-06-08Sell5,000$19.99-0.3 view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-06-04Sell787$19.581.79 view
Marth William SPresident and CEO 2015-06-04Buy10,000$19.98-0.25 view
Hagen Steven RSVP Manufacturing & Pharmaceut 2015-06-02Sell3,750$19.392.78 view
CABLE STUART M10% Owner 2015-06-01Sell30,000$19.691.22 view
D AMBRA THOMAS E PHDDirector 2015-05-11Sell20,000$19.114.29 view

Quarterly/Annual Reports about AMRI:

    News about AMRI:

    Articles On GuruFocus.com
    Weekly CFO Buys Highlight: TSON, PRTS, FXCM, AMRI, MN Dec 05 2011 
    View on AMRI Jun 27 2010 
    AMRI Announces Second Quarter 2009 Results Aug 04 2009 
    AMRI Announces Fourth Quarter 2008 Results Feb 09 2009 
    AMRI Names Senior Director, Analytical and Quality Services Jan 12 2009 

    More From Other Websites
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement Aug 19 2015
    ALBANY MOLECULAR RESEARCH INC Financials Aug 18 2015
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Regulation FD Disclosure Aug 12 2015
    10-Q for Albany Molecular Research, Inc. Aug 09 2015
    ALBANY MOLECULAR RESEARCH INC Files SEC form 10-Q, Quarterly Report Aug 07 2015
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Aug 05 2015
    Edited Transcript of AMRI earnings conference call or presentation 4-Aug-15 12:30pm GMT Aug 04 2015
    Albany Molecular Research posts 2Q profit Aug 04 2015
    Albany Molecular Research posts 2Q profit Aug 04 2015
    Albany Molecular Research Inc Earnings Call scheduled for 8:30 am ET today Aug 04 2015
    AMRI Announces Second Quarter 2015 Results Aug 04 2015
    Q2 2015 Albany Molecular Research Inc Earnings Release - Before Market Open Aug 04 2015
    PerkinElmer Beats Q2 Earnings and Revenues; Guides Up - Analyst Blog Jul 31 2015
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jul 29 2015
    AMRI to Announce Second Quarter 2015 Results Jul 21 2015
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 16 2015
    AMRI Acquires Gadea Pharmaceutical Group Jul 16 2015
    AMRI and IBM projects in Buffalo represent transitioning businesses Jul 09 2015
    Edited Transcript of AMRI presentation 1-Jun-15 7:30pm GMT Jun 25 2015
    AMRI continues to build Buffalo partnerships Jun 19 2015
    AMRI and PerkinElmer Announce Drug Discovery Collaboration as part of the Buffalo Medical Innovation... Jun 17 2015
    ALBANY MOLECULAR RESEARCH INC Files SEC form 8-K, Change in Directors or Principal Officers,... Jun 05 2015
    HarkerBio signs three-year deal with AMRI Jun 01 2015
    Albany Molecular Research posts 1Q loss May 05 2015
    Albany Molecular Research posts 4Q loss Feb 12 2015
    Albany Molecular Research posts 3Q loss Nov 05 2014

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK